TME Pharma NV (ALTME) EUR1

Sell:€0.10Buy:€0.10€0.00 (1.48%)

Prices delayed by at least 15 minutes
Sell:€0.10
Buy:€0.10
Change:€0.00 (1.48%)
Prices delayed by at least 15 minutes
Sell:€0.10
Buy:€0.10
Change:€0.00 (1.48%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
26 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
50,000€0.10€5,000.002,975,000
25 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
135,000€0.10€13,500.002,925,000
24 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
65,000€0.10€6,500.002,790,000
23 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
30,000€0.10€3,000.002,725,000
22 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
95,000€0.10€9,500.002,695,000
19 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
300,000€0.09€27,000.002,600,000

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
300,000€0.09€27,000.002,600,000
25 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
135,000€0.10€13,500.002,925,000
22 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
95,000€0.10€9,500.002,695,000
24 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
65,000€0.10€6,500.002,790,000
26 September 2025
Diede Mink Van Den OudenCEO
Buy
Regular purchase transaction
50,000€0.10€5,000.002,975,000

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.